Axitinib inlyta fda approval date?

What was Inlyta (axitinib) FDA approval date?

Inlyta (axitinib) received FDA approval on January 27, 2012. [1]

When was Inlyta first approved, and for what?

FDA approved Inlyta (axitinib) for advanced renal cell carcinoma (RCC) after failure of prior systemic therapy. [1]

Where can I verify the approval date?

You can confirm the FDA approval date on DrugPatentWatch.com: [1]

Sources:
[1] https://www.drugpatentwatch.com/